Multiple Sclerosis and Related Disorders

Predictors of early serologic diagnosis of AQ4-IgG positive NMOSD 2:18
Predictors of early serologic diagnosis of AQ4-IgG positive NMOSD
Dalia Rotstein • 27 Oct 2022
Safety and efficacy of aHSCT for MS 1:51
Safety and efficacy of aHSCT for MS
Riccardo Saccardi • 28 Oct 2022
mHealth for rehabilitation of multiple sclerosis patients 1:10
mHealth for rehabilitation of multiple sclerosis patients
Peter Feys • 28 Oct 2022
Lipid-based therapies for MS 2:13
Lipid-based therapies for MS
Gesine Saher • 4 Nov 2022
Technology-supported rehabilitation in multiple sclerosis 2:32
Technology-supported rehabilitation in multiple sclerosis
Peter Feys • 28 Oct 2022
Lipids in MS: future research & treatment approaches 2:58
Lipids in MS: future research & treatment approaches
Gesine Saher • 4 Nov 2022
Profiling cognitive-motor interference & fatigability in progressive MS 1:50
Profiling cognitive-motor interference & fatigability in progressive MS
Peter Feys • 28 Oct 2022
Motor and cognitive dual-task capacity in people with MS 1:06
Motor and cognitive dual-task capacity in people with MS
Peter Feys • 28 Oct 2022
Guidelines for aHSCT in MS 1:44
Guidelines for aHSCT in MS
Riccardo Saccardi • 28 Oct 2022
Barriers to the use of internet-based technology by people with MS 2:41
Barriers to the use of internet-based technology by people with MS
Yael Goverover • 27 Oct 2022
Cognitive rehabilitation for patients with multiple sclerosis 4:10
Cognitive rehabilitation for patients with multiple sclerosis
Yael Goverover • 27 Oct 2022
Brain MRI vs. spinal cord MRI in measuring cervical spinal cord atrophy 2:15
Brain MRI vs. spinal cord MRI in measuring cervical spinal cord atrophy
Burcu Zeydan • 27 Oct 2022
Increased use of internet-based technologies in individuals with MS 3:19
Increased use of internet-based technologies in individuals with MS
Yael Goverover • 27 Oct 2022
Differential diagnosis of MS patients using serum proteomics: disease state & MS subtype 2:13
Differential diagnosis of MS patients using serum proteomics: disease state & MS subtype
Ferhan Qureshi • 26 Oct 2022
When to make a timely switch to high-efficacy DMT for MS 0:47
When to make a timely switch to high-efficacy DMT for MS
Dalia Rotstein • 27 Oct 2022
Future research on cognitive rehabilitation interventions for MS patients 2:24
Future research on cognitive rehabilitation interventions for MS patients
Yael Goverover • 27 Oct 2022
The content of VJNeurology is intended for healthcare professionals